Jan. 6, 2014
/PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the 32
Annual J.P. Morgan Healthcare Conference on
Wednesday, January 15, 2014
, Cyberonics' President and Chief Executive Officer, will speak at
10:00 AM Pacific Time
. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at
About Cyberonics, Inc. and the VNS Therapy ® System
Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation. The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.
Additional information on Cyberonics and the VNS Therapy System is available at
, CFOCyberonics, Inc.100 Cyberonics Blvd.
77058Main: (281) 228-7262Fax: (281) 218-9332
SOURCE Cyberonics, Inc.